Bioness
Neuromuscular Electrical Stimulation Systems
Company Overview
Snapshot
Founded in March 1991 by Shmuel Shani, Bioness operates with 51–200 employees. The company was acquired by Accelmed in October 2024.
Business overview
Bioness develops medical technologies, including neuromodulation systems, robotic systems, and software-based therapy programs. These solutions provide functional and therapeutic benefits for individuals with central nervous system disorders and orthopedic injuries. The company's products aim to enhance efficiencies, improve patient outcomes, and increase safety for healthcare providers, operating within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.
Strategic signal
In January 2025, Bioness Medical, Inc. re-established itself as an independent neuro-rehabilitation-focused organization. This move signals a strategic re-commitment to advancing patient outcomes through innovative therapeutic technology, with a renewed emphasis on developing a technology roadmap in collaboration with clinical partners. This indicates a strong forward trajectory in rehabilitation technology and a focus on specialized market needs.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant recent corporate event for Bioness?
- In October 2024, Bioness was acquired by Accelmed. This acquisition was part of Bioventus Inc.'s divestiture of its Advanced Rehabilitation business.
- What was the strategic rationale behind the October 2024 acquisition?
- The acquisition of Bioness by Accelmed in October 2024 allowed Bioventus Inc. to focus on its core operations and enhance liquidity, while Accelmed gained a key asset in the rehabilitation technology space.
- What is the current operational status of Bioness?
- In January 2025, Bioness Medical, Inc. re-established itself as an independent neuro-rehabilitation-focused organization, aiming to advance patient outcomes through innovative therapeutic technology.
- Who is the CEO leading the re-established Bioness Medical, Inc.?
- Todd Cushman returned as CEO of Bioness Medical, Inc. in January 2025, emphasizing the company's commitment to supporting patients with mobility-impacting conditions.
- When was Bioness previously acquired?
- In March 2021, Bioness was acquired by Bioventus.